Article Details
Retrieved on: 2025-01-17 15:31:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Medicare's plan to negotiate drug prices, including Ozempic, under the Inflation Reduction Act. This aims to reduce costs for GLP-1 inhibitors like Ozempic, impacting healthcare reform and out-of-pocket expenses significantly.
Article found on: www.investopedia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here